Cargando…
Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597178/ http://dx.doi.org/10.1186/1546-0096-13-S1-P1 |
| _version_ | 1782393878382379008 |
|---|---|
| author | Brogan, P Hofer, M Kuemmerle-Deschner, J Lauwerys, B Speziale, A Abrams, K Leon, K Wei, X Laxer, R |
| author_facet | Brogan, P Hofer, M Kuemmerle-Deschner, J Lauwerys, B Speziale, A Abrams, K Leon, K Wei, X Laxer, R |
| author_sort | Brogan, P |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4597178 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45971782015-10-08 Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab Brogan, P Hofer, M Kuemmerle-Deschner, J Lauwerys, B Speziale, A Abrams, K Leon, K Wei, X Laxer, R Pediatr Rheumatol Online J Poster Presentation BioMed Central 2015-09-28 /pmc/articles/PMC4597178/ http://dx.doi.org/10.1186/1546-0096-13-S1-P1 Text en Copyright © 2015 Brogan et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Brogan, P Hofer, M Kuemmerle-Deschner, J Lauwerys, B Speziale, A Abrams, K Leon, K Wei, X Laxer, R Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab |
| title | Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab |
| title_full | Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab |
| title_fullStr | Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab |
| title_full_unstemmed | Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab |
| title_short | Efficacy, safety, and post-vaccination antibody titer data in children with CAPS treated with Canakinumab |
| title_sort | efficacy, safety, and post-vaccination antibody titer data in children with caps treated with canakinumab |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597178/ http://dx.doi.org/10.1186/1546-0096-13-S1-P1 |
| work_keys_str_mv | AT broganp efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT hoferm efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT kuemmerledeschnerj efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT lauwerysb efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT spezialea efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT abramsk efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT leonk efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT weix efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab AT laxerr efficacysafetyandpostvaccinationantibodytiterdatainchildrenwithcapstreatedwithcanakinumab |